nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormal Flow Conditions Promote Endocardial Fibroelastosis Via Endothelial-to-Mesenchymal Transition, Which Is Responsive to Losartan Treatment
|
Oh, Nicholas A. |
|
|
|
12 |
p. 984-999 |
artikel |
2 |
Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction
|
Louwe, Mieke C. |
|
|
|
12 |
p. 1210-1224 |
artikel |
3 |
A Novel Device for Tricuspid Regurgitation Reduction Featuring 3-Dimensional Leaflet and Atraumatic Anchor
|
Chon, Min-Ku |
|
|
|
12 |
p. 1249-1261 |
artikel |
4 |
A Novel Puncturable Atrial Septal Defect Occluder
|
Zhang, Xiaochun |
|
|
|
12 |
p. 1200-1210 |
artikel |
5 |
Atrial Septal Defect Closure With the ReAces Device
|
Alkhouli, Mohamad |
|
|
|
12 |
p. 1211-1213 |
artikel |
6 |
Biochemical Structure and Function of TRAPP Complexes in the Cardiac System
|
Papaioannou, Peter |
|
|
|
12 |
p. 1599-1612 |
artikel |
7 |
Calcific Aortic Valve Disease “Omics” Is Timely, But Are We Looking Too Late? ∗
|
Atkins, Samantha K. |
|
|
|
12 |
p. 1178-1180 |
artikel |
8 |
Can Mesenchymal Stem Cell–Derived Therapeutics Protect the Developing Brain During Cardiac Surgery? ∗
|
Hansmann, Georg |
|
|
|
12 |
p. 1536-1538 |
artikel |
9 |
Cardiovascular Research in Friedreich Ataxia
|
Payne, R. Mark |
|
|
|
12 |
p. 1267-1283 |
artikel |
10 |
Comprehensive Assessment of High-Risk Plaques by Dual-Modal Imaging Catheter in Coronary Artery
|
Kim, Sunwon |
|
|
|
12 |
p. 948-960 |
artikel |
11 |
Correction
|
|
|
|
|
12 |
p. 1264-1265 |
artikel |
12 |
Correction
|
|
|
|
|
12 |
p. 1284-1285 |
artikel |
13 |
Crizanlizumab
|
Gue, Ying X. |
|
|
|
12 |
p. 946-947 |
artikel |
14 |
Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived From the Dark Genome
|
Viereck, Janika |
|
|
|
12 |
p. 1595-1598 |
artikel |
15 |
Editorial Board
|
|
|
|
|
12 |
p. A1-A3 |
artikel |
16 |
Editorial Board
|
|
|
|
|
12 |
p. A1-A3 |
artikel |
17 |
Editorial Board
|
|
|
|
|
12 |
p. A1-A3 |
artikel |
18 |
Editorial Board
|
|
|
|
|
12 |
p. A1-A3 |
artikel |
19 |
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19
|
Leucker, Thorsten M. |
|
|
|
12 |
p. 935-945 |
artikel |
20 |
Extracellular Matrix Protein-1 as a Mediator of Inflammation-Induced Fibrosis After Myocardial Infarction
|
Hardy, Sean A. |
|
|
|
12 |
p. 1539-1554 |
artikel |
21 |
Full Issue PDF
|
|
|
|
|
12 |
p. I-CII |
artikel |
22 |
Full Issue Pdf
|
|
|
|
|
12 |
p. I-CVI |
artikel |
23 |
Full Issue PDF
|
|
|
|
|
12 |
p. I-CXLIII |
artikel |
24 |
Full Issue Pdf
|
|
|
|
|
12 |
p. I-CVI |
artikel |
25 |
Genetic Ablation of the DNA Damage Response Pathway Attenuates Lamin-Associated Dilated Cardiomyopathy in Mice
|
Cheedipudi, Sirisha M. |
|
|
|
12 |
p. 1232-1245 |
artikel |
26 |
Growing With the Flow
|
Pek, Nicole Min Qian |
|
|
|
12 |
p. 1000-1002 |
artikel |
27 |
Improving Polygenic Risk Scores for Coronary Artery Disease
|
Ajufo, Ezimamaka C. |
|
|
|
12 |
p. 1500-1502 |
artikel |
28 |
In Situ Heart Valve Tissue Engineering
|
Mela, Petra |
|
|
|
12 |
p. 1207-1209 |
artikel |
29 |
In Situ Remodeling Overrules Bioinspired Scaffold Architecture of Supramolecular Elastomeric Tissue-Engineered Heart Valves
|
Uiterwijk, Marcelle |
|
|
|
12 |
p. 1187-1206 |
artikel |
30 |
Integration of Biomarker Polygenic Risk Score Improves Prediction of Coronary Heart Disease
|
Lin, Jake |
|
|
|
12 |
p. 1489-1499 |
artikel |
31 |
Junctional Ectopic Tachycardia Caused by Junctophilin-2 Expression Silencing Is Selectively Sensitive to Ryanodine Receptor Blockade
|
Yang, Qixin |
|
|
|
12 |
p. 1577-1588 |
artikel |
32 |
Landscape of Mentorship and its Effects on Success in Cardiology
|
Abudayyeh, Islam |
|
|
|
12 |
p. 1181-1186 |
artikel |
33 |
Mesenchymal Stromal Cell Delivery Via Cardiopulmonary Bypass Provides Neuroprotection in a Juvenile Porcine Model
|
Sarkislali, Kamil |
|
|
|
12 |
p. 1521-1535 |
artikel |
34 |
Metabolomic Signature of Human Aortic Valve Stenosis
|
Surendran, Arun |
|
|
|
12 |
p. 1163-1177 |
artikel |
35 |
Metabolomic Signatures of Myocardial Glucose Uptake on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography
|
Vidula, Mahesh K. |
|
|
|
12 |
p. 1264-1266 |
artikel |
36 |
Mind the Gap
|
Glukhov, Alexey V. |
|
|
|
12 |
p. 1589-1591 |
artikel |
37 |
New Insights Into the Therapy for Lamin-Associated Dilated Cardiomyopathy ∗
|
Zhang, Hao |
|
|
|
12 |
p. 1246-1248 |
artikel |
38 |
NLRP3 Inflammasome Inhibition
|
Narendran, Siddharth |
|
|
|
12 |
p. 1225-1227 |
artikel |
39 |
PD-1 Checkmate and the 2-Edged Sword of the Immune System
|
Cunningham, Madeleine W. |
|
|
|
12 |
p. 1518-1520 |
artikel |
40 |
Phosphorylcholine Antibodies Preserve Cardiac Function and Reduce Infarct Size by Attenuating the Post-Ischemic Inflammatory Response
|
Pluijmert, Niek J. |
|
|
|
12 |
p. 1228-1239 |
artikel |
41 |
Platelets
|
Sellers, Stephanie L. |
|
|
|
12 |
p. 1007-1020 |
artikel |
42 |
Pleiotropic, Cellular Effects of Rivaroxaban on Autophagy Explain Atheroprotective Effects ∗
|
Posma, Jens J.N. |
|
|
|
12 |
p. 981-983 |
artikel |
43 |
Recurrent Adrenergic Stress Provokes Persistent Myocarditis in PD-1–Deficient Mice
|
Hayashi, Tomohiro |
|
|
|
12 |
p. 1503-1517 |
artikel |
44 |
Reduce, Reuse, Recycle…Unloading, Autophagy, and Myocardial Recovery ∗
|
Ambardekar, Amrut V. |
|
|
|
12 |
p. 1229-1231 |
artikel |
45 |
Return of the Tricuspid Spacer
|
Fam, Neil P. |
|
|
|
12 |
p. 1262-1263 |
artikel |
46 |
Rivaroxaban, a Direct Oral Factor Xa Inhibitor, Attenuates Atherosclerosis by Alleviating Factor Xa–PAR2-Mediated Autophagy Suppression
|
Ito, Yusuke |
|
|
|
12 |
p. 964-980 |
artikel |
47 |
RNA Vaccines for COVID-19
|
Lin, Chien-Jung |
|
|
|
12 |
p. 1240-1243 |
artikel |
48 |
Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction
|
Wang, Dennis D. |
|
|
|
12 |
p. 1183-1196 |
artikel |
49 |
Synergizing Light and Machine Learning to Comprehensively Reveal Coronary Plaque Composition ∗
|
Osborn, Eric A. |
|
|
|
12 |
p. 961-963 |
artikel |
50 |
Tackling Inflammation at its Source in Heart Failure
|
Sack, Michael N. |
|
|
|
12 |
p. 1197-1199 |
artikel |
51 |
TAK1 Activation by NLRP3 Deficiency Confers Cardioprotection Against Pressure Overload-Induced Cardiomyocyte Pyroptosis and Hypertrophy
|
Li, Xuan |
|
|
|
12 |
p. 1555-1573 |
artikel |
52 |
Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure
|
Evans, Sarah |
|
|
|
12 |
p. 1214-1228 |
artikel |
53 |
The Cardiac Circadian Clock
|
Young, Martin E. |
|
|
|
12 |
p. 1613-1628 |
artikel |
54 |
The CNP/NPR-B/cGMP Axis is a Therapeutic Target in Calcific Aortic Stenosis
|
Armstrong, David W.J. |
|
|
|
12 |
p. 1003-1006 |
artikel |
55 |
The Effect of Exercise Training on Muscle Coenzyme Q10 in Symptomatic and Asymptomatic Statin Users
|
Allard, Neeltje A.E. |
|
|
|
12 |
p. 1592-1594 |
artikel |
56 |
Tit for TAK1
|
Dundas, Jameson A. |
|
|
|
12 |
p. 1574-1576 |
artikel |
57 |
Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
|
Prisco, Sasha Z. |
|
|
|
12 |
p. 1244-1260 |
artikel |
58 |
Update on Cardioprotective Strategies for STEMI
|
Kloner, Robert A. |
|
|
|
12 |
p. 1021-1033 |
artikel |
59 |
Will COVID-19 Transform Translational Medicine?
|
Mann, Douglas L. |
|
|
|
12 |
p. 1261-1263 |
artikel |